JPMorgan Chase Reports Strong Earnings for Q1 2025
April 11, 2025
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, Dec. 11, 2023. Brendan ...
Federal Trade Commission Chair Lina Khan testifies during a hearing of the House Appropriations Subcommittee on Financial Services and General ...
Check out the companies making headlines before the bell. Morphic Holding — Shares surged more than 75% on news that ...
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of ...
A leading provider of exchange-traded funds, Roundhill Investments, is wagering on the enduring appeal of GLP-1 weight loss medications.Last week, ...
Copyright © 2024 Fermat Ventures.
Fermat Ventures is not responsible for the content of external sites.
The content on this website is for informational purposes only and is not professional advice. By proceeding, you agree that Fermat Ventures Ltd. is not responsible for how you use this information. You also agree to our Privacy Policy, Disclaimer, and Terms and Conditions.
Copyright © 2024 Fermat Ventures.
Fermat Ventures is not responsible for the content of external sites.